ABCS.CN - Abacus Health Products, Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
6.51
-0.59 (-8.31%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close7.10
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume71,896
Market Cap140.479M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateApr 29, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Charlotte's Web Acquires Abacus Health Products
      PR Newswire

      Charlotte's Web Acquires Abacus Health Products

      Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") (TSX: CWEB) (OTCQX: CWBHF), the company behind the world's most trusted hemp extract, and Abacus Health Products, Inc. ("Abacus") (CSE: ABCS) (OTCQB: ABAHF), a leader in over-the-counter topical products combining active pharmaceutical ingredients with hemp extract, are pleased to announce that they have completed the previously-announced plan of arrangement (the "Arrangement"). Pursuant to the Arrangement, Charlotte's Web acquired all the issued and outstanding subordinate voting shares of Abacus (the "Abacus Shares"). All the outstanding proportionate voting shares of Abacus were converted into Abacus Shares prior to closing of the Arrangement. Pursuant to the Arrangement, holders of Abacus Shares received 0.85 (the "Exchange Ratio") of a common share of Charlotte's Web for each Abacus Share held at the time of closing.

    • Abacus Health Products Receives Court Approval for Arrangement with Charlotte’s Web
      Business Wire

      Abacus Health Products Receives Court Approval for Arrangement with Charlotte’s Web

      Abacus Health Products Inc. receives final court order approving its acquisition by Charlotte's Web Holdings Inc.

    • Abacus Health Products’ Shareholders Approve Arrangement with Charlotte’s Web
      Business Wire

      Abacus Health Products’ Shareholders Approve Arrangement with Charlotte’s Web

      Abacus Health Products Inc. shareholders approve the company's acquisition by Charlotte's Web Holdings Inc.

    • Abacus Health Products Reports First Quarter 2020 Financial Results
      Business Wire

      Abacus Health Products Reports First Quarter 2020 Financial Results

      Abacus Health Products Inc. reports its first quarter 2020 financial results.

    • Abacus Health Products Announces ISS and Glass Lewis Recommendations For its Proposed Acquisition by Charlotte’s Web; Change to Virtual Only Special Meeting of Shareholders
      Business Wire

      Abacus Health Products Announces ISS and Glass Lewis Recommendations For its Proposed Acquisition by Charlotte’s Web; Change to Virtual Only Special Meeting of Shareholders

      Abacus Health Products announces recommendations for its proposed acquisition by Charlotte’s Web; Change to virtual only Special Meeting

    • Abacus Health Products Announces Release Date for 2020 First Quarter Financial Results
      Business Wire

      Abacus Health Products Announces Release Date for 2020 First Quarter Financial Results

      Abacus Health Products Inc. announces the release date for its 2020 first quarter financial results.

    • GlobeNewswire

      REPEAT - Novamind and Buzz Capital Announce Qualifying Transaction

      Buzz Capital Inc. (TSXV:BUZ.P) ("Buzz Capital" or the "Corporation"), a capital pool company listed on the TSX Venture Exchange (the "Exchange"), is pleased to announce that it has signed a letter of intent dated May 8, 2020 (the "Letter of Intent") with Novamind Ventures Inc., an Ontario corporation, ("Novamind”) to complete a business combination by way of a transaction that will constitute a reverse takeover of Buzz Capital by Novamind. The proposed transaction is intended to constitute an arm’s length qualifying transaction (the "Qualifying Transaction") for Buzz Capital, as defined in Policy 2.4 of the Exchange.

    • GlobeNewswire

      Novamind and Buzz Capital Announce Qualifying Transaction

      Buzz Capital Inc. (TSXV:BUZ.P) ("Buzz Capital" or the "Corporation"), a capital pool company listed on the TSX Venture Exchange (the "Exchange"), is pleased to announce that it has signed a letter of intent dated May 8, 2020 (the "Letter of Intent") with Novamind Ventures Inc., an Ontario corporation, ("Novamind”) to complete a business combination by way of a transaction that will constitute a reverse takeover of Buzz Capital by Novamind. The proposed transaction is intended to constitute an arm’s length qualifying transaction (the "Qualifying Transaction") for Buzz Capital, as defined in Policy 2.4 of the Exchange.

    • Abacus Health Products Announces Special Meeting of Shareholders and Filing of Meeting Materials for Arrangement with Charlotte’s Web
      Business Wire

      Abacus Health Products Announces Special Meeting of Shareholders and Filing of Meeting Materials for Arrangement with Charlotte’s Web

      Abacus Health Products announces special meeting and filing of materials for arrangement with Charlotte's Web.

    • Abacus Health Products Reports Fourth Quarter and Year-End 2019 Financial Results
      Business Wire

      Abacus Health Products Reports Fourth Quarter and Year-End 2019 Financial Results

      Abacus Health Products reports Fourth Quarter & Year-End financial results; revenues increase 82% and gross profit increases 68% year-over-year.

    • Abacus Health Products Announces Release Date, Conference Call Details for 2019 Fourth Quarter and Year-End Financial Results
      Business Wire

      Abacus Health Products Announces Release Date, Conference Call Details for 2019 Fourth Quarter and Year-End Financial Results

      Abacus Health Products Inc. announces 2019 Fourth Quarter and Year End financial results release date and conference call details.

    • Rob Gronkowski is Back in the Game with CBDMEDIC™
      PR Newswire

      Rob Gronkowski is Back in the Game with CBDMEDIC™

      Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) ("Abacus" or the "Company") today announces its support of Rob Gronkowski's (Gronk), three-time professional football champion, decision to return to play professional football. Gronkowski partnered with Abacus following nine years of playing in New England. His relationship with Abacus is as a result of his focused effort to recover from the injuries sustained throughout his 9-season career. Following his retirement from professional football in March 2019, Rob Gronkowski announced his partnership with Abacus Health Products, the company behind CBDMEDIC topical pain relief products. In doing so, Gronkowski became an outspoken advocate for CBD in an effort to help athletes and people suffering with pain.

    • Rob Gronkowski Is "Back in The Game" with CBDMEDIC™
      Business Wire

      Rob Gronkowski Is "Back in The Game" with CBDMEDIC™

      Rob Gronkowski attributes his return to professional football in part to Abacus Health Products' CBDMEDIC.

    • Rob Gronkowski, Camille Kostek and Matt Iseman Team Up With CBDMEDIC™ to Launch "Survive & Thrive: COVID-19 LIVE Celebrity Challenge" To Generate Support for the Arthritis Foundation
      PR Newswire

      Rob Gronkowski, Camille Kostek and Matt Iseman Team Up With CBDMEDIC™ to Launch "Survive & Thrive: COVID-19 LIVE Celebrity Challenge" To Generate Support for the Arthritis Foundation

      Three-time football champion Rob Gronkowski, Sports Illustrated Swimsuit Issue cover model Camille Kostek, and several more celebrities have teamed up with CBDMEDIC™ to host a live, online fundraising challenge to benefit the Arthritis Foundation's severely at-risk, elderly and immunocompromised populations who have been disproportionately impacted by the COVID-19 crisis. To help raise critical crisis funds, celebrities will be participating in "Survive & Thrive: COVID-19 Celebrity Challenge," which will be livestreamed on the Facebook channel of the Arthritis Foundation on Wednesday, April 22, 2020, at 8 p.m. ET. American Ninja Warrior television host and M.D., Matt Iseman, will moderate the event.

    • CNW Group

      Horizons ETFS Rebalances Marijuana-Focused Index ETF Suite

      Horizons ETFS Rebalances Marijuana-Focused Index ETF Suite

    • Landrace Bioscience Announces New Supply Chain and Product Development Services Agreement with Abacus Health Products
      PR Newswire

      Landrace Bioscience Announces New Supply Chain and Product Development Services Agreement with Abacus Health Products

      Landrace Bioscience, Inc., a science and research-driven hemp ingredient manufacturer and leader in custom product formulation solutions, announced today their partnership with Abacus Health Products, Inc. (OTC: ABAHF, CSE: ABCS), wherein Landrace will immediately begin supplying hemp extracts for Abacus' leading over-the-counter, non-prescription topical brands, CBDMEDIC™ and CBDCLINIC™. The Company will also be working with Abacus to develop new products for former professional football champion and Abacus spokesperson, Rob Gronkowski's, upcoming cannabidiol (CBD) line.

    • ACCESSWIRE

      Abacus Health Products to Present at the LD Micro Main Event (XII)

      Abacus' leading consumer brand, CBDMEDIC, includes a line of topical pain relief and skincare products. Abacus' leadership in the CBD market is underscored by its announcement that it has received purchase orders from approximately 7,000 retail locations representing 20 chains including the 3 largest national retail pharmacy chains. To schedule a one-on-one meeting with Abacus Health Products, you may submit your request online via the link provided upon registration or email your request to wade@ldmicro.com.

    • Canadian Securities Exchange Attracts First Israeli Company Listings
      Newsfile

      Canadian Securities Exchange Attracts First Israeli Company Listings

      IM Cannabis becomes third Israeli cannabis listing in past six weeks Toronto, Ontario--(Newsfile Corp. - November 5, 2019) - The Canadian Securities Exchange ("CSE" or "the Exchange") welcomes the listing of three Israel-based companies on the Exchange over the past six weeks: InnoCan Pharma Corp. (CSE: INNO), Isracann Biosciences Inc. (CSE: IPOT), and IM Cannabis Corp. (CSE: IMCC), which began trading today. ...

    • Rob Gronkowski on his new CBD partnership, NFL future
      Yahoo Finance

      Rob Gronkowski on his new CBD partnership, NFL future

      Football star Rob Gronkowski is partnering with Abacus Health (ABAHF), a publicly traded CBD company listed in Canada, the maker of CBDMEDIC.

    • Rob Gronkowski Becomes an Advocate for CBD And Partners with Abacus Health Products, Maker of CBDMEDIC
      PR Newswire

      Rob Gronkowski Becomes an Advocate for CBD And Partners with Abacus Health Products, Maker of CBDMEDIC

      NEW YORK, Aug. 27, 2019 /PRNewswire/ -- Rob Gronkowski, three-time professional football champion with several records to his name, today announced that he has become an advocate for CBD and an investor in Abacus Health Products (ABCS.CN)(ABAHF) ("Abacus" or the "Company"). Abacus is the maker of CBDMEDIC, the first family of all-natural topical medications that combine over the counter (OTC) drug active ingredients with CBD-rich hemp oil and other natural moisturizers.

    • CNW Group

      IIROC Trade Resumption - ABCS

      IIROC Trade Resumption - ABCS

    • CNW Group

      IIROC Trading Halt - ABCS

      IIROC Trading Halt - ABCS

    • Abacus Health Products Announces Addition to Board of Directors
      CNW Group

      Abacus Health Products Announces Addition to Board of Directors

      WOONSOCKET, RI and TORONTO , July 31, 2019 /CNW/ - Abacus Health Products, Inc. ("Abacus" or the "Company") (CSE: ABCS) (ABAHF) is pleased to announce that Mr. Hannan Fleiman has joined its board of directors.  Mr. Fleiman will also serve as Chair of the Company's Audit Committee and Corporate Governance, Nominating and Compensation Committee. With the addition of Mr. Fleiman, Abacus now has a total of five directors on its board. "I am pleased to welcome Hannan Fleiman to Abacus' board of directors," said Perry Antelman , CEO of Abacus.